Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploring Relationships Among Peripheral Amyloid Beta, Tau, Cytokines, Cognitive Function, and Psychosomatic Symptoms in Breast Cancer Survivors
Ashley M. Henneghan, Andreana P. Haley, Shelli R. Kesler
Biological Research For Nursing (2019) Vol. 22, Iss. 1, pp. 126-138
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Long-Term Cognitive Dysfunction in Cancer Survivors
Zuzana Országhová, Michal Mego, Michal Chovanec
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 102
Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy
AnnaLynn M. Williams, Raven Shah, Michelle Shayne, et al.
Journal of Neuroimmunology (2017) Vol. 314, pp. 17-23
Open Access | Times Cited: 84
Randomized Controlled Trial of Virtually Delivered Cognitive Behavioral Therapy for Insomnia to Address Perceived Cancer-Related Cognitive Impairment in Cancer Survivors
Sheila N. Garland, Joshua Tulk, Josée Savard, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 17, pp. 2094-2104
Closed Access | Times Cited: 6
Loneliness: An Immunometabolic Syndrome
Homa Pourriyahi, Niloufar Yazdanpanah, Amene Saghazadeh, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 22, pp. 12162-12162
Open Access | Times Cited: 40
A Cross-Sectional Exploration of Cytokine–Symptom Networks in Breast Cancer Survivors Using Network Analysis
Ashley M. Henneghan, Michelle L. Wright, Garrett Bourne, et al.
Canadian Journal of Nursing Research (2020) Vol. 53, Iss. 3, pp. 303-315
Open Access | Times Cited: 28
Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: A scoping review
Kate Oppegaard, Terri S. Armstrong, Joaquin A. Anguera, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 180, pp. 103822-103822
Open Access | Times Cited: 17
Neurocognitive Impairment After Hematopoietic Stem Cell Transplant for Hematologic Malignancies: Phenotype and Mechanisms
Rebecca A. Harrison, Noha Sharafeldin, Jennie L. Rexer, et al.
The Oncologist (2021) Vol. 26, Iss. 11, pp. e2021-e2033
Open Access | Times Cited: 20
Blood and neuroimaging biomarkers of cognitive sequelae in breast cancer patients throughout chemotherapy: A systematic review
Gwen Schroyen, Julie Vissers, Ann Smeets, et al.
Translational Oncology (2021) Vol. 16, pp. 101297-101297
Open Access | Times Cited: 19
Cognitive complications of cancer and cancer-related treatments – Novel paradigms
Naomi Lomeli, Javier Lepe, Kalpna Gupta, et al.
Neuroscience Letters (2021) Vol. 749, pp. 135720-135720
Open Access | Times Cited: 18
Plasma levels of interleukin‐6 mediate neurocognitive performance in older breast cancer survivors: The Thinking and Living With Cancer study
Jeanne S. Mandelblatt, Brent J. Small, Xingtao Zhou, et al.
Cancer (2023) Vol. 129, Iss. 15, pp. 2409-2421
Closed Access | Times Cited: 7
Cancer-related cognitive impairment in racial and ethnic minority groups: a scoping review
Oscar Y. Franco‐Rocha, Kimberly Lewis, Kayla D. Longoria, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 13, pp. 12561-12587
Closed Access | Times Cited: 7
Nicotinic and Muscarinic Acetylcholine Receptor Agonists Counteract Cognitive Impairment in a Rat Model of Doxorubicin-Induced Chemobrain via Attenuation of Multiple Programmed Cell Death Pathways
Benjamin Ongnok, Nanthip Prathumsap, Titikorn Chunchai, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 2
A scoping review evaluating physical and cognitive functional outcomes in cancer survivors treated with chemotherapy: charting progress since the 2018 NCI think tank on cancer and aging phenotypes
Mostafa Mohamed, Mustafa M. Ahmed, AnnaLynn M. Williams, et al.
Journal of Cancer Survivorship (2024) Vol. 18, Iss. 4, pp. 1089-1130
Open Access | Times Cited: 2
Alzheimer disease–related biomarkers and cancer-related cognitive decline: the Thinking and Living with Cancer study
Jeanne S. Mandelblatt, Jeffrey L. Dage, Xingtao Zhou, et al.
JNCI Journal of the National Cancer Institute (2024) Vol. 116, Iss. 9, pp. 1495-1507
Closed Access | Times Cited: 2
Dietary EPA and DHA enrichment of a high fat diet during doxorubicin-based chemotherapy attenuated neuroinflammatory gene expression in the brain of C57bl/6 ovariectomized mice
Kate Ormiston, Z. Melink, Rebecca Andridge, et al.
Brain Behavior and Immunity (2024)
Closed Access | Times Cited: 2
Infliximab and/or MESNA alleviate doxorubicin-induced Alzheimer's disease-like pathology in rats: A new insight into TNF-α/Wnt/β-catenin signaling pathway
Hoda E. Mohamad, Dina M. Abo‐Elmatty, Nehal S. Wahba, et al.
Life Sciences (2022) Vol. 301, pp. 120613-120613
Closed Access | Times Cited: 12
Distinct sleep disturbance and cognitive dysfunction profiles in oncology outpatients receiving chemotherapy
Vivian Huang, Lynda Mackin, Kord M. Kober, et al.
Supportive Care in Cancer (2022) Vol. 30, Iss. 11, pp. 9243-9254
Closed Access | Times Cited: 9
Neuroimaging based biotypes for precision diagnosis and prognosis in cancer-related cognitive impairment
Shelli R. Kesler, Ashley M. Henneghan, Sarah Prinsloo, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 5
Distinct cytokine profiles across trajectories of self-perceived cognitive impairment among early-stage breast cancer survivors
Yi Long Toh, Claire Wang, Han Kiat Ho, et al.
Journal of Neuroimmunology (2020) Vol. 342, pp. 577196-577196
Open Access | Times Cited: 12
Nasal administration of mesenchymal stem cells prevents accelerated age-related tauopathy after chemotherapy in mice
Miriam Zamorano, Jenolyn F. Alexander, Desiree Catania, et al.
Immunity & Ageing (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 4
Neurotoxicity of the antineoplastic drugs: “Doxorubicin” as an example
Ghadha Ibrahim Fouad, Maha Z. Rizk
Journal of Molecular Histology (2024)
Closed Access | Times Cited: 1
Changes in Brain Functional and Effective Connectivity After Treatment for Breast Cancer and Implications for Intervention Targets
Nicholas S. Phillips, Vikram Rao, Lorie Kmetz, et al.
Brain Connectivity (2021) Vol. 12, Iss. 4, pp. 385-397
Open Access | Times Cited: 10
Altered immunoemotional regulatory system in COVID-19: From the origins to opportunities
Homa Pourriyahi, Amene Saghazadeh, Nima Rezaei
Journal of Neuroimmunology (2021) Vol. 356, pp. 577578-577578
Open Access | Times Cited: 9
Brain morphological alterations and their correlation to tumor differentiation and duration in patients with lung cancer after platinum chemotherapy
Pin Lv, Guolin Ma, Wenqian Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4
Dual Effects: Intrastriatal Injection of α-syn N103/tau N368 Preformed Fibrils Promotes Endogenous α-synuclein Aggregates in the Proximal Colon
Jialing Wang, Xiaoman Yang, Weiqi Zeng, et al.
Journal of Parkinson s Disease (2022) Vol. 12, Iss. 7, pp. 2097-2116
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top